2007
DOI: 10.1073/pnas.0611643104
|View full text |Cite
|
Sign up to set email alerts
|

Virstatin inhibits dimerization of the transcriptional activator ToxT

Abstract: The development of antimicrobials is critical in this time of increasing antibiotic resistance of most clinically relevant bacteria. To date, all current antibiotics focus on inhibiting crucial enzymatic activities of their protein targets (i.e., trimethoprim for dihydrofolate reductase), thus disrupting in vitro essential gene functions. In contrast, we have previously reported the identification of virstatin, a small molecule that inhibits virulence regulation in Vibrio cholerae, thereby preventing intestina… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
129
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 117 publications
(135 citation statements)
references
References 26 publications
(29 reference statements)
5
129
1
Order By: Relevance
“…The type 2 interaction is very spacing sensitive, as a difference of even 1 bp from the wild-type spacing abrogates transcription activation at some promoters. However, the acfA and aldA promoters were the promoters least sensitive to virstatin treatment (37), suggesting that the type 2 interaction is virstatin insensitive. A type 3 interaction occurs between ␣-CTD and ToxT at a distal toxbox oriented so that it "points away" from the promoter.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…The type 2 interaction is very spacing sensitive, as a difference of even 1 bp from the wild-type spacing abrogates transcription activation at some promoters. However, the acfA and aldA promoters were the promoters least sensitive to virstatin treatment (37), suggesting that the type 2 interaction is virstatin insensitive. A type 3 interaction occurs between ␣-CTD and ToxT at a distal toxbox oriented so that it "points away" from the promoter.…”
Section: Discussionmentioning
confidence: 96%
“…Furthermore, insertion of 5 or 10 bp between the promoter-proximal toxbox and the Ϫ35 box at the tcpA promoter also abrogated transcription activation by ToxT (unpublished data), suggesting that the spacing of the toxboxes relative to the promoter is important for activation. There is evidence from domain swapping experiments that ToxT Nterminal domains can associate with each other to form dimers or multimers (33,37), but full-length ToxT was not observed to dimerize in such an assay (37). It is possible that ToxT monomers associate with each other at some promoters and that this association is important for transcription activation.…”
mentioning
confidence: 99%
“…Consequently, development of anti-virulence drugs is proceeding (Waldor, 2006). An example is the small molecule inhibitor of V. cholerae intestinal colonization, virstatin [N-(1, 8-(naphthalimide)-n-butyric acid], which was identified in a high-throughput phenotypic screen (Hung et al, 2005;Shakhnovich et al, 2007Shakhnovich et al, , 2007a. This molecule inhibits ctxAB and tcpA transcription by preventing dimerization of their positive regulator, ToxT (Shakhnovich et al, 2007a).…”
Section: Significance To Anti-virulence Drug Discoverymentioning
confidence: 99%
“…An example is the small molecule inhibitor of V. cholerae intestinal colonization, virstatin [N-(1, 8-(naphthalimide)-n-butyric acid], which was identified in a high-throughput phenotypic screen (Hung et al, 2005;Shakhnovich et al, 2007Shakhnovich et al, , 2007a. This molecule inhibits ctxAB and tcpA transcription by preventing dimerization of their positive regulator, ToxT (Shakhnovich et al, 2007a). Another example is the newly identified inhibitor of the Na + -dependent flagellar motor, Q24DA, which could prevent infection dissemination by blocking motility and indirectly diminishing CT and TCP secretion (Rasmussen et al, 2010.…”
Section: Significance To Anti-virulence Drug Discoverymentioning
confidence: 99%
“…To examine whether dimerization played a role in the transcriptional regulation of msh genes by ToxT, we examined the effects of a known inhibitor of ToxT dimerization, virstatin (14,24), on the transcription of msh genes in E. coli (Fig. 1A).…”
Section: Identification Of Toxt Regulatory Sites At the Msh Locusmentioning
confidence: 99%